• Echocardiography for COVID-19

    Recent evidence suggests that patients with severe COVID-19 pneumonia may present cardiac complications such as acute myocardial injury and myocarditis.

    Echocardiography can help to quickly identify the circulatory status and guide hemodynamic management for these patients.

    Nevertheless, in hard hit areas, non-ICU and non-cardiology specialists are being asked to take on larger management roles and perform basic echo scan to COVID-19 patients.

  • US Mentor COVID-19 Module Point-of-Care Lung Ultrasound Training
  • Lung Ultrasound

    Published evidence based on Chinese and Italian experience with COVID-19 patients shares the advantages of lung ultrasound and suggests that it has an important role in patient assessment and monitoring the evolution of the disease.

    Lung ultrasound is considered an alternative to chest radiography or CT scanning in COVID-19 patients.  It is safe, easy and quick for use at point-of-care, repeatable, low cost and radiation-free.

    Training front line physicians to rapidly acquire the lung ultrasound skills can be critical for the success of COVID-19 management.

Available Cases:

  • Lung Ultrasound

    • Step by Step Task – Blue Protocol
    • Healthy Patient
    • Mild COVID-19 Patient
    • Moderate COVID-19 Patient
    • Severe COVID-19 Patient
  • Echocardiography

    • Step by Step Task – Bedside Echocardiography views
    • COVID-19 patient with Normal echo findings
    • COVID-19 patient with Acute Myocarditis
    • COVID-19 patient with Pulmonary Hypertension

Educational Materials:

The module includes a rich video and document educational library, lung ultrasound and echocardiography basics, COVID-19 typical findings, triage and disinfection protocols, created in collaboration with international emergency medicine, critical care, pulmonary and intensive care experts.

During the pandemic, educational materials are open to the medical community in our e-learning resources.

  • Pneumonia Simbionix COVID-19 Module


  • Patient Scenario

    Medical history and complaints:

    38-year-old female, previously diagnosed with asthma, admitted to the emergency department due to 3 days of fever, presenting cough and shortness of breath.

    Patient was in self-quarantine due to a recent encounter with COVID-19 patient. She was tested for COVID-19 and now waiting for the laboratory test results.

    Physical examination results:

    • Blood pressure: 155/78 mmHg
    • Heart rate: 126 beats per minute
    • Respiratory rate: 36 breaths per minute
    • Saturation: 95% with 15l O2 / minute given to patient using Venturi mask system
    • Prolonged expiration and wheezing present
    • Lung auscultation: Expiratory wheezing present bilaterally
    • Heart auscultation: No murmurs
  • Lung Ultrasound and Echocardiography COVID-19 Publications

The module was developed in collaboration with the following experts:

  • Abdulrazak F. Alchakaki, MD
    Pulmonary and Critical Care Specialist
    Beaumont Hospital
    Trenton, MI USA

  • Shirley Friedman, MD
    PICU attending physician
    Dana-Dwek Children's Hospital
    Tel Aviv Sourasky Medical Center

  • Ron Berant, MD
    Attending Physician
    Lead physician for Point Of Care Ultrasound
    Pediatric Emergency Medicine
    Schneider Children’s Medical Center of Israel

  • Lior Fuchs, MD
    Intensive Care Unit
    Soroka University Medical Center
    Beer-Sheva, Israel

  • Neal F. Chaisson, MD
    Director, Critical Care Medicine Fellowship
    Respiratory Institute
    Cleveland Clinic, Cleveland, Ohio

  • Abdulghani Sankari, MD, Ph.D
    Associate Professor of Medicine
    Division of Pulmonary/Critical Care and Sleep Medicine
    Wayne State University-School of Medicine
    Detroit Medical Center
    Detroit, MI USA

  • Steven W. Fox, MD
    Fellow, Pulmonary and Critical Care Medicine
    Cleveland, Ohio

Get More Information on the COVID-19 Module

Which finance offer is most important to you?
1= Not important at all and 10 = Extremely important

I agree the items, technology/technical data and/or services will not be used for any purposes, to include design, production, assembly, testing, operation, integration, installation, inspection, maintenance, repair, overhaul, or refurbishment, related to a military or defense application or military End-Use or by a military End-User in the People’s Republic of China, Venezuela, Burma (Myanmar) or Russia; or any other country, state or province named in US Regulation 744.21 Supplement 2. The product(s) software, and/or technology acquired from 3D Systems will not be re-exported, sold or otherwise re-sold or transferred to a destination subject to UN, EU or OSCE embargo where that act would be in breach of the terms of that embargo sold, or transferred inviolate on of Council Regulation (EC) No 428/2009 setting up a Community regime for the control of exports, transfer, brokering and transit of dual-use items;We will not sell, transfer, export, or re-export any items received from 3D Systems for use in activities that involve nuclear explosive activities; unsafeguarded nuclear activities; nuclear fuel cycle or nuclear propulsion activities; or in the design, development, production, stockpiling, or use of chemical weapons, biological weapons, missiles, rocket systems or unmanned aerial vehicles (UAV)

I consent to receive 3D Systems Communications
Would you like to receive special offers, product updates, and event news from 3D Systems? By clicking "Yes", you agree to receive follow-up communications from 3D Systems or our partners. You can also choose to opt out of communications at any time. Please click here to view our Privacy Policy or click here to manage your Preferences.